Is it time to give up your annual mammogram?
If you dread your annual mammogram, you’re not alone. For many women, this breast cancer screening examination can be painful, stressful, and just an overall hassle.
You may wonder, are you old enough to give it up? If you’re over age 75, the answer is: maybe or maybe not. The fact is, breast cancer screening isn’t right for all older adults, but there’s no expert consensus on the right age to stop. This is mostly because scientific evidence in this area is lacking, says Dr. Kathryn Rexrode, associate professor of medicine at Harvard Medical School and chief of the Division of Women’s Health at Brigham and Womenâ...
Source: Harvard Health Blog - May 1, 2020 Category: Consumer Health News Authors: Kelly Bilodeau Tags: Breast Cancer Healthy Aging Managing your health care Screening Women's Health Source Type: blogs
Medications That Can Cause Depression
There is nothing more frustrating than when the cure is part of the problem. Because depression is prevalent in patients with physical disorders like cancer, stroke, and heart disease, medications often interact with each other, complicating treatment. To appropriately manage depression, you and your physician need to evaluate all medications involved and make sure they aren’t cancelling each other out.
A review in the journal Dialogues in Clinical Neuroscience a while back highlighted certain medications that can cause depression. The following are medications to watch out for.
Medications to Treat Seizures and Parkinso...
Source: World of Psychology - March 31, 2019 Category: Psychiatry & Psychology Authors: Therese J. Borchard Tags: Depression Medications Drug Interactions Mood Disorder Source Type: blogs
More'Uplifting' News on Breast Cancer Recurrences
Sometimes I wish they would stop researching breast cancer so we stop getting such ' good ' news. New research was meant to look at whether some hormone receptor positive breast cancer patientscould stop taking tamoxifen or aromatase inhibitors such as Femara, Aromasin, or Arimidex. However they found instead that ER/PR+ breast cancers can ' smolder ' (their word, not mine) for twenty years or more, before recurring.Aromatase inhibitors and tamoxifen inhibit the production of estrogen which feeds these ER/PR+ breast cancers. The longer you are on the medication, the longer you are protected from a recurrence. However, some...
Source: Caroline's Breast Cancer Blog - February 3, 2018 Category: Cancer & Oncology Tags: breast cancer treatment cancer research frustration Source Type: blogs
Why Bother?
For some reason I have had a similar conversation with different women on the same topic: why take tamoxifen or aromatase inhibitors after initial breast cancer treatment. Aromatase inhibitors are Arimidex (anastrozole), Aromasin (exemestane), and Femara (letrozole)The conversations all boil down to:What if I get side effects? They have heard they are awful and could cause them some real problems. But if you don ' t even try them how will you know if you will experience the side effects?What exactly do they do? They don ' t really understand that they would reduce their recurrence risk by being on themWhy do I have to be o...
Source: Caroline's Breast Cancer Blog - March 8, 2017 Category: Cancer & Oncology Tags: doctors medications side effects Source Type: blogs
On The Pulse - 20th December 2013
Anastrozole for the prevention of breast cancer (Source: OnMedica Blogs)
Source: OnMedica Blogs - December 20, 2013 Category: Health Medicine and Bioethics Commentators Source Type: blogs
A Crestor Blog Ad About a Crestor TV Ad About a Crestor TV Ad. Humor Fails to Educate.
AstraZeneca just posted a Crestor ad about a Crestor ad about a Crestor ad on AZ Health Connections, which is "A blog for AstraZeneca's US business." The blog post -- see screen capture below -- was written by Rod Wooten, Commercial Brand Leader, CRESTOR. It's an authentic direct-to-consumer (DTC) ad and includes all the FDA-required information, including the brief statement about major side effects.The post is titled "AstraZeneca Takes a New Advertising Approach to Engage & Educate Consumers" (find it here). I have a few words to say about the "new" approach below, but right now let's just savor the "unique" approach...
Source: Pharma Marketing Blog - October 1, 2013 Category: Pharma Commentators Tags: corporate blogs AstraZeneca Cholesterol Crestor DTC Source Type: blogs
AstraZeneca Posts an Arimidex DTC Ad on Its Corporate Blog - Will It Go Viral?
AstraZeneca is breaking new ground in social media drug promotion... again. It has posted a branded promotion for its breast cancer drug Arimidex on AZ Health Connections, which is "A blog for AstraZeneca's US business."The post -- titled "AstraZeneca’s ARIMIDEX® (anastrozole) tablets Direct program provides valuable resources to program enrollees"-- promotes ARIMIDEX Direct, which is AstraZeneca’s "first-ever direct-to-patient program. It enables eligible patients to easily enroll and receive brand-name ARIMIDEX delivered directly to their home for $40 per month, including shipping."There is no doubt that in the...
Source: Pharma Marketing Blog - August 17, 2013 Category: Pharma Commentators Tags: Arimidex AstraZeneca AZ Health Connections breast cancer DTC Advertising Pharma Blogosphere Source Type: blogs
